ABOUT US

Development History

线条3
100
Complete the research and development of SARS-CoV-2 products and launch them. It is expected to complete the launch plan of chemiluminescence products and multi-channel fluorescence immunoassay analyzers.
线条3
100
Passed the recognition of national high-tech enterprise, undertook the special project of Zhujiang scie.
线条3
100
Undertook the special project of the Pearl River Science and Technology Rising Star in Guangzhou for scientific research and innovation talents, and obtained the registration certificate of Songyi series products.
线条3
100
Participated in the Pearl River Scientific and Technological Rising Star Special Project in Guangzhou.
线条3
100
Passed the national high-tech enterprise certification and passed the Guangzhou Development Zone Gazelle Enterprise Certification.
线条3
100
The first domestic chest pain 5 in 1 Combo detection product obtained the registration certificate, and passed the Guangzhou enterprise R&D organization construction project certification.
线条3
100
Passed the quality management system ISO13485 certification and obtained the registration certificate.
线条3
100
Launched a series of rapid test products for infection and cardiovascular disease, and passed the national high-tech enterprise certification.
线条3
100
Cardiovascular diagnostic reagents and fluorescence immunoassay analyzers obtained registration certificates and participated in the provincial-ministerial industry-university-research cooperation project.
线条3
100
Obtained the production license for clinical inspection and analysis instruments.
线条3
100
Obtained the diagnostic reagent production license.
线条3
100
Graduated from Guangzhou Science City International Incubator and entered Yushu Industrial Park
100
线条3
The company was formally established and was approved to enter the Guangzhou Science City Innovation Base